Carlson Capital’s DexCom DXCM Stock Holding History

Carlson Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-356,400	Closed	-$7.81M	–	296
2016 Q3	$7.81M	Sell	356,400 -61,800	-15%	-$1.38M	0.1%	197
2016 Q2	$8.29M	Buy	+418,200	New	+$7.12M	0.1%	213

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Carlson Capital's DXCM Position: Q4 2016 in Review

Carlson Capital sold out of DexCom (DXCM) in Q4 2016, closing a stake of 356,400 shares — an estimated $7.81M sold.

Carlson Capital first reported a position in DXCM in Q2 2016 and held it in 2 quarters. The position peaked at $8.29M in Q2 2016. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

Carlson Capital reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
Carlson Capital sold 356,400 DexCom shares in Q4 2016, an estimated $7.81M.
Carlson Capital first reported a position in DexCom in Q2 2016 and held it in 2 quarters.
Carlson Capital's DexCom position peaked at $8.29M in Q2 2016.
316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on Carlson Capital's 13F filing for Q4 2016, filed 14 Feb 2017.